{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T06:39:01Z","timestamp":1777703941738,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":2790,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Slovenian Research Agency","doi-asserted-by":"crossref","award":["P1-0170, P3-0003, and L3-0449"],"award-info":[{"award-number":["P1-0170, P3-0003, and L3-0449"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1093\/annonc\/mdr324","type":"journal-article","created":{"date-parts":[[2011,7,16]],"date-time":"2011-07-16T07:35:06Z","timestamp":1310801706000},"page":"961-967","source":"Crossref","is-referenced-by-count":27,"title":["The influence of platinum pathway polymorphisms on the outcome in patients with malignant mesothelioma"],"prefix":"10.1016","volume":"23","author":[{"given":"N.","family":"Er\u010dulj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Kova\u010d","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Hmeljak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Dol\u017ean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdr324_bb0010","first-page":"260","article-title":"Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province","volume":"17","author":"Wagner","year":"1960","journal-title":"Br J Ind Med"},{"key":"10.1093\/annonc\/mdr324_bb0015","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/sj.bjc.6602307","article-title":"The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050","volume":"92","author":"Hodgson","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdr324_bb0020","series-title":"Proceedings of the European Conference on Asbestos Risk and Management, Rome, Italy","first-page":"43","article-title":"Predicted incidence of mesothelioma in Slovenia","author":"Dodic Fikfak","year":"2006"},{"key":"10.1093\/annonc\/mdr324_bb0025","unstructured":"AScherpereelPAstoulPBaasGuidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesotheliomaEur Respir J35479495"},{"key":"10.1093\/annonc\/mdr324_bb0030","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","article-title":"Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma","volume":"27","author":"Krug","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr324_bb0035","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0169-5002(02)00180-0","article-title":"Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis","volume":"38","author":"Berghmans","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1093\/annonc\/mdr324_bb0040","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr324_bb0045","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.lungcan.2008.09.008","article-title":"Outcomes with first-line platinum-based combination chemotherapy for malignant pleural mesothelioma: a review of practice in British Columbia","volume":"64","author":"Lee","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1093\/annonc\/mdr324_bb0050","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/FPC.0b013e3280115e63","article-title":"Single nucleotide polymorphisms of the DNA repair gene XPD\/ERCC2 alter mRNA expression","volume":"17","author":"Wolfe","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1093\/annonc\/mdr324_bb0055","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1289\/ehp.6632","article-title":"Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays","volume":"111","author":"Au","year":"2003","journal-title":"Environ Health Perspect"},{"key":"10.1093\/annonc\/mdr324_bb0060","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/carcin\/21.4.551","article-title":"XPD polymorphisms: effects on DNA repair proficiency","volume":"21","author":"Lunn","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1093\/annonc\/mdr324_bb0065","first-page":"5911","article-title":"Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells","volume":"54","author":"Johnson","year":"1994","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdr324_bb0070","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.ejca.2008.12.013","article-title":"A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer","volume":"45","author":"Vergote","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdr324_bb0075","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1017\/S0007114509992066","article-title":"Modulation of nucleotide excision repair in human lymphocytes by genetic and dietary factors","volume":"103","author":"Langie","year":"2009","journal-title":"Br J Nutr"},{"key":"10.1093\/annonc\/mdr324_bb0080","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1158\/1055-9965.EPI-06-0218","article-title":"Polymorphisms in nucleotide excision repair genes and DNA repair capacity phenotype in sisters discordant for breast cancer","volume":"15","author":"Shen","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/annonc\/mdr324_bb0085","first-page":"8097","article-title":"Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors","volume":"63","author":"Cullen","year":"2003","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdr324_bb0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ctrv.2008.07.003","article-title":"An overview of the relations between polymorphisms in drug metabolising enzymes and drug transporters and survival after cancer drug treatment","volume":"35","author":"Ekhart","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"10.1093\/annonc\/mdr324_bb0095","doi-asserted-by":"crossref","first-page":"10004","DOI":"10.1074\/jbc.272.15.10004","article-title":"Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins","volume":"272","author":"Ali-Osman","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1093\/annonc\/mdr324_bb0100","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/carcin\/19.2.275","article-title":"Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution","volume":"19","author":"Watson","year":"1998","journal-title":"Carcinogenesis"},{"key":"10.1093\/annonc\/mdr324_bb0105","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000028396","article-title":"Glutathione S-transferase polymorphisms and their biological consequences","volume":"61","author":"Hayes","year":"2000","journal-title":"Pharmacology"},{"key":"10.1093\/annonc\/mdr324_bb0110","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1200\/JCO.2004.08.067","article-title":"XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy","volume":"22","author":"Gurubhagavatula","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr324_bb0115","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jss.2009.09.006","article-title":"Excision repair cross complementation group 1 polymorphisms predict overall survival after platinum-based chemotherapy for completely resected non-small-cell lung cancer","volume":"168","author":"Okuda","year":"2011","journal-title":"J Surg Res"},{"key":"10.1093\/annonc\/mdr324_bb0120","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1158\/1078-0432.CCR-04-0247","article-title":"Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy","volume":"10","author":"Zhou","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdr324_bb0125","first-page":"8654","article-title":"A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer","volume":"61","author":"Park","year":"2001","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdr324_bb0130","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/jnci\/94.12.936","article-title":"Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer","volume":"94","author":"Stoehlmacher","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdr324_bb0135","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ygyno.2009.01.002","article-title":"Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: a Korean population-based study","volume":"113","author":"Kim","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdr324_bb0140","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/tpj.2009.19","article-title":"Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients","volume":"9","author":"Caronia","year":"2009","journal-title":"Pharmacogenomics J"},{"key":"10.1093\/annonc\/mdr324_bb0145","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/FPC.0b013e32832f3010","article-title":"Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes","volume":"19","author":"Bradbury","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"10.1093\/annonc\/mdr324_bb0150","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/FPC.0b013e3283304253","article-title":"Functional glutathione S-transferase genotypes among testicular germ cell tumor survivors: associations with primary and post-chemotherapy tumor histology","volume":"19","author":"Kraggerud","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"10.1093\/annonc\/mdr324_bb0155","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mdh059","article-title":"Modified RECIST criteria for assessment of response in malignant pleural mesothelioma","volume":"15","author":"Byrne","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr324_bb0160","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/030089161009600504","article-title":"No implication of Simian virus 40 in pathogenesis of malignant pleural mesothelioma in Slovenia","volume":"96","author":"Hmeljak","year":"2010","journal-title":"Tumori"},{"key":"10.1093\/annonc\/mdr324_bb0165","first-page":"229","article-title":"Genetic polymorphisms of glutathione S-transferases and disease activity of rheumatoid arthritis","volume":"27","author":"Bohanec Grabar","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1093\/annonc\/mdr324_bb0170","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/bioinformatics\/btm058","article-title":"A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies","volume":"23","author":"Tregouet","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1093\/annonc\/mdr324_bb0175","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/sj.ejhg.5201238","article-title":"Cox proportional hazards survival regression in haplotype-based association analysis using the Stochastic-EM algorithm","volume":"12","author":"Tregouet","year":"2004","journal-title":"Eur J Hum Genet"},{"key":"10.1093\/annonc\/mdr324_bb0180","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ncponc1039","article-title":"Advances in the systemic therapy of malignant pleural mesothelioma","volume":"5","author":"Fennell","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1093\/annonc\/mdr324_bb0185","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1158\/1078-0432.CCR-10-2873","article-title":"Thymidylate synthase and excision repair cross-complementing group-1 as predictors of responsiveness in mesothelioma patients treated with pemetrexed\/carboplatin","volume":"17","author":"Zucali","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdr324_bb0190","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.bjc.6601975","article-title":"A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU\/oxaliplatin combination chemotherapy in refractory colorectal cancer","volume":"91","author":"Stoehlmacher","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdr324_bb0195","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/COC.0b013e3181b9cedc","article-title":"Association between polymorphisms of ERCC1 and XPD and clinical response to platinum-based chemotherapy in advanced non-small cell lung cancer","volume":"33","author":"Li","year":"2010","journal-title":"Am J Clin Oncol"},{"key":"10.1093\/annonc\/mdr324_bb0200","first-page":"127","volume":"22","author":"Seo","year":"2009","journal-title":"Oncol Rep"},{"key":"10.1093\/annonc\/mdr324_bb0205","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/tpj.2009.45","article-title":"Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients","volume":"10","author":"Khrunin","year":"2009","journal-title":"Pharmacogenomics J"},{"key":"10.1093\/annonc\/mdr324_bb0210","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1158\/1078-0432.CCR-04-1953","article-title":"Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients","volume":"11","author":"Suk","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdr324_bb0215","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1101\/gr.109371.110","article-title":"Identification of cis- and trans-regulatory variation modulating microRNA expression levels in human fibroblasts","volume":"21","author":"Borel","year":"2010","journal-title":"Genome Res"},{"key":"10.1093\/annonc\/mdr324_bb0220","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1158\/1078-0432.CCR-05-2076","article-title":"Glutathione S-transferase P1 polymorphism (Ile105Val) predicts cumulative neuropathy in patients receiving oxaliplatin-based chemotherapy","volume":"12","author":"Lecomte","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdr324_bb0225","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1158\/1055-9965.EPI-09-0871","article-title":"Glutathione pathway genetic polymorphisms and lung cancer survival after platinum-based chemotherapy","volume":"19","author":"Moyer","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/annonc\/mdr324_bb0230","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(08)60727-8","article-title":"Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial","volume":"371","author":"Muers","year":"2008","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdr324_bb0235","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/sj.bjc.6601061","article-title":"Lack of involvement of nucleotide excision repair gene polymorphisms in colorectal cancer","volume":"89","author":"Mort","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdr324_bb0240","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2217\/14622416.6.8.873","article-title":"Concordance of pharmacogenetic markers in germline and colorectal tumor DNA","volume":"6","author":"Marsh","year":"2005","journal-title":"Pharmacogenomics"},{"key":"10.1093\/annonc\/mdr324_bb0245","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1158\/1055-9965.EPI-06-0964","article-title":"Concordance of pharmacogenetic polymorphisms in tumor and germ line DNA in adult patients with acute myeloid leukemia","volume":"16","author":"Weiss","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/annonc\/mdr324_bb0250","series-title":"HLA 1998","first-page":"180","article-title":"Slovenian Caucasian normal","author":"Vidan-Jeras","year":"1998"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419346356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419346356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/23\/4\/961\/13785170\/mdr324.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T13:14:20Z","timestamp":1627478060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419346356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0923753419346356"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdr324","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}